title: Optimization studies on gastroretentive floating system using response surface methodology.
abstract: The aim of the present investigation was to develop and optimize gastroretentive floating system of amoxicillin for the efficient treatment of peptic ulcer induced by Helicobacter pylori infection. Floating microballoons were developed using central composite design (CCD), and optimization was done by employing response surface methodology. The selected independent variables were cellulose acetate phthalate, drug-Eudragit S100 ratio, and the ratio of dichloromethane/ethanol/isopropyl alcohol. The selected dependent variables were yield, mean particle size, buoyancy, encapsulation efficiency, and drug release within 8 h. A quadratic polynomial model was generated which had linear, interaction, and quadratic terms to predict and evaluate the independent variables with respect to the dependent variables. Results showed that selected independent variables significantly affect the yield (30.53-82.71%), particle size (31.62-47.03 μm), buoyancy (42.68-95.75%), encapsulation efficiency (56.96-93.13%), and cumulative drug release from the microballoons (34.01-74.65%). The interaction and quadratic terms were also found to affect the process variables. An excellent agreement was found between the actual value and predicted value. In conclusion, it can be said that CCD is a valuable second-degree design to develop and optimize GFS of amoxicillin which in turn provides a basis to localize the drug release in the gastric region for effective treatment of H. pylori-mediated infection.
authors.affiliation: Laureate Institute of Pharmacy, Dehra, Dist Kangra, Himachal Pradesh, India.
authors.forename: Rajendra
authors.initials: R
authors.lastname: Awasthi
authors.forename: Giriraj T
authors.initials: GT
authors.lastname: Kulkarni
authors.forename: Vivek K
authors.initials: VK
authors.lastname: Pawar
authors.forename: Garima
authors.initials: G
authors.lastname: Garg
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D005753:Gastric Mucosa / Q000378:metabolism; D016481:Helicobacter Infections / Q000188:drug therapy / Q000378:metabolism; D008863:Microspheres; D010316:Particle Size; D013270:Stomach / Q000187:drug effects; D013499:Surface Properties; D014961:X-Ray Diffraction
chemical_list: D000658:Amoxicillin